249 related articles for article (PubMed ID: 24243633)
1. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.
Avitan-Hersh E; Tatur S; Indelman M; Gepstein V; Shreter R; Hershkovitz D; Brick R; Bergman R; Tiosano D
J Clin Endocrinol Metab; 2014 Jan; 99(1):E132-6. PubMed ID: 24243633
[TBL] [Abstract][Full Text] [Related]
2. RAS in FGF23: another piece in the puzzle.
Ovejero D; Collins MT
J Clin Endocrinol Metab; 2014 Jan; 99(1):63-6. PubMed ID: 24384015
[No Abstract] [Full Text] [Related]
3. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytic epidermal nevi associated with localized fibro-osseous lesions without hypophosphatemia.
Mestach L; Polubothu S; Calder A; Denayer E; Gholam K; Legius E; Levtchenko E; Van Laethem A; Brems H; Kinsler VA; Morren MA
Pediatr Dermatol; 2020 Sep; 37(5):890-895. PubMed ID: 32662096
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.
Lim YH; Ovejero D; Derrick KM; ; Collins MT; Choate KA
J Am Acad Dermatol; 2016 Aug; 75(2):420-7. PubMed ID: 27444071
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
7. Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source.
Ovejero D; Michel Z; Cataisson C; Saikali A; Galisteo R; Yuspa SH; Collins MT; de Castro LF
J Clin Invest; 2023 May; 133(9):. PubMed ID: 36943390
[TBL] [Abstract][Full Text] [Related]
8. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.
Ovejero D; Lim YH; Boyce AM; Gafni RI; McCarthy E; Nguyen TA; Eichenfield LF; DeKlotz CM; Guthrie LC; Tosi LL; Thornton PS; Choate KA; Collins MT
Osteoporos Int; 2016 Dec; 27(12):3615-3626. PubMed ID: 27497815
[TBL] [Abstract][Full Text] [Related]
10. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
[TBL] [Abstract][Full Text] [Related]
11. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
Weber TJ; Liu S; Indridason OS; Quarles LD
J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
[TBL] [Abstract][Full Text] [Related]
12. Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.
Li JY; Berger MF; Marghoob A; Bhanot UK; Toyohara JP; Pulitzer MP
J Cutan Pathol; 2014 Aug; 41(8):663-71. PubMed ID: 24628623
[TBL] [Abstract][Full Text] [Related]
13. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
[TBL] [Abstract][Full Text] [Related]
14. Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi.
Igawa S; Honma M; Minami-Hori M; Tsuchida E; Iizuka H; Ishida-Yamamoto A
J Dermatol; 2016 Jan; 43(1):103-4. PubMed ID: 26498739
[No Abstract] [Full Text] [Related]
15. Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.
Ichikawa S; Guigonis V; Imel EA; Courouble M; Heissat S; Henley JD; Sorenson AH; Petit B; Lienhardt A; Econs MJ
J Clin Endocrinol Metab; 2007 May; 92(5):1943-7. PubMed ID: 17311862
[TBL] [Abstract][Full Text] [Related]
16. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
Imel EA; Hui SL; Econs MJ
J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
[TBL] [Abstract][Full Text] [Related]
17. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
[TBL] [Abstract][Full Text] [Related]
18. Keratinocytic epidermal nevus with oral involvement and cleft palate.
Menni S; Boccardi D; Gualandri L
G Ital Dermatol Venereol; 2008 Oct; 143(5):347-9. PubMed ID: 18833076
[TBL] [Abstract][Full Text] [Related]
19. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]